HSPA1A and cancer: In addition to triggering innate immunity, the covalent conjugation of antigenic proteins/peptides to HSPs and the generation of HSP fusion proteins such as HSP70, can generate efficient antigen-specific T cell immunity [28,29] and has been employed in vaccine design for infectious diseases and cancers [30].